Dev

Development of SLIC, a methodology for synthetic lethal screening in the CNS Investments > €500k United States of America Huntington’s disease 2016    

Influence of genotype on microglia phenotype and function in PD Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection Investments > €500k United States of America Motor neurone diseases 2016    

Combined Multi-Pinhole and Fan-Beam Brain SPECT Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

The role of gut endocrine cells in Parkinsons Disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Evaluation of glucocerebrosidase pathway biomarkers in Parkinson Disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Structure and Function of the Parkinsons disease associated protein LRRK2 Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Functions of alpha-Synuclein in Neurotransmitter Release Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Developing neuroprotective strategies for proteinopathy Investments > €500k United States of America Motor neurone diseases 2016    

Targeting the Ubiquitin Proteasome System to Treat Spinal Muscular Atrophy Investments > €500k United States of America Spinal muscular atrophy (SMA) 2016